Literature DB >> 32075479

Success of Big Infectious Disease Reimbursement Policy in China.

Kun-Xi Nie1, Chan Wang2, Xin-Wu Li2.   

Abstract

Big infectious diseases do harm to the whole society, and it is highly crucial to control them on time. The major purpose of this article is to theoretically demonstrate that the Chinese government's intervention in large-scale infectious diseases is successful and efficient. Two potential strategies were considered: strategy 1 was infectious disease without government intervention, and strategy 2 was infectious disease with government intervention. By evolution model, this article illustrates the efficiency of big infectious disease reimbursement policy in China. Without government reimbursement, this article finds that high expenditures accelerate the disease infection. The number of infected persons decreases under big infectious disease reimbursement policy in China. The higher the treatment costs, the more important the government intervention. Big infectious disease reimbursement policy in China can serve as an efficient example to cope with big infectious diseases.

Entities:  

Keywords:  China; efficiency; infectious disease; reimbursement policy; treatment costs

Year:  2020        PMID: 32075479     DOI: 10.1177/0046958020907788

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  1 in total

1.  Explaining the challenges of the Iranian Health System in fighting the COVID-19 pandemic: A Qualitative Study.

Authors:  Tahereh Shafaghat; Mohammad Kazem Rahimi Zarchi; Seyed Masood Mousavi; Roohollah Askari; Mohammad Ranjbar; Faezeh Ebadi
Journal:  J Prev Med Hyg       Date:  2022-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.